Loading...
NUS logo

Nu Skin Enterprises, Inc.NYSE:NUS Stock Report

Market Cap US$287.9m
Share Price
US$5.89
US$5.03
17.2% overvalued intrinsic discount
1Y-22.2%
7D3.3%
1D
Portfolio Value
​
View

Nu Skin Enterprises, Inc.

NYSE:NUS Stock Report

Market Cap: US$287.9m

Nu Skin Enterprises (NUS) Stock Overview

Engages in the development and distribution of various beauty and wellness products worldwide. More details

NUS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance1/6
Financial Health6/6
Dividends3/6

Rewards

Price-To-Earnings ratio (5.2x) is below the US market (18.6x)

Earnings are forecast to grow 13.85% per year

Became profitable this year

Trading at good value compared to peers and industry

Risk Analysis

Large one-off items impacting financial results

Unstable dividend track record


NUS Community Fair Values

Create Narrative

See what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Nu Skin Enterprises, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nu Skin Enterprises
Historical stock prices
Current Share PriceUS$5.89
52 Week HighUS$14.62
52 Week LowUS$5.62
Beta1.02
1 Month Change-21.88%
3 Month Change-31.11%
1 Year Change-22.19%
3 Year Change-82.68%
5 Year Change-90.33%
Change since IPO-79.51%

Recent News & Updates

Analysis Article • May 18

Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues

The market shrugged off Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) solid earnings report. We did some digging and believe...

Recent updates

Analysis Article • May 18

Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues

The market shrugged off Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) solid earnings report. We did some digging and believe...
Seeking Alpha • Feb 25

Nu Skin: Patience Is Still Advised

Summary Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin expansion and a return to revenue growth by late 2026, with India and Prysm iO launches as key potential drivers. Non-core assets and a net cash-positive balance sheet provide some downside protection, but secular decline in legacy markets remains a major overhang. With execution risk high and no clear stabilization, waiting for tangible signs of turnaround before entry is prudent despite the low valuation. Read the full article on Seeking Alpha
Analysis Article • Jan 17

Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk

There wouldn't be many who think Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) price-to-sales (or "P/S") ratio of 0.4x is...
Analysis Article • Oct 12

Here's Why Nu Skin Enterprises (NYSE:NUS) Has A Meaningful Debt Burden

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jul 24

Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Fly 28% But Investors Aren't Buying For Growth

Despite an already strong run, Nu Skin Enterprises, Inc. ( NYSE:NUS ) shares have been powering on, with a gain of 28...
Analysis Article • Jul 24

A Look At The Fair Value Of Nu Skin Enterprises, Inc. (NYSE:NUS)

Key Insights The projected fair value for Nu Skin Enterprises is US$9.54 based on 2 Stage Free Cash Flow to Equity Nu...
Analysis Article • May 30

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • May 12

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

Nu Skin Enterprises, Inc. ( NYSE:NUS ) has announced that it will pay a dividend of $0.06 per share on the 11th of...
Analysis Article • Apr 23

Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Nu Skin Enterprises, Inc. ( NYSE:NUS ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article • Apr 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When researching a stock for investment, what can tell us that the company is in decline? A business that's potentially...
Analysis Article • Mar 25

Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?

Nu Skin Enterprises, Inc. ( NYSE:NUS ), might not be a large cap stock, but it saw a double-digit share price rise of...
Analysis Article • Mar 06

Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified

Nu Skin Enterprises, Inc. ( NYSE:NUS ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Feb 17

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06

Nu Skin Enterprises, Inc. ( NYSE:NUS ) will pay a dividend of $0.06 on the 5th of March. This means the dividend yield...
Analysis Article • Feb 15

Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Seeking Alpha • Jan 09

Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth

Summary Nu Skin Enterprises sold its Mavely affiliate marketing platform for $250 million, achieving a 5x ROI since 2021, and plans to use the cash for debt reduction and innovation. The new cash influx could accelerate both inorganic and organic growth, with potential acquisitions enhancing revenue and free cash flow growth. NUS could benefit from potential tax reductions under the new U.S. administration, which may increase net income and stock demand. Despite risks from tariffs, foreign-currency fluctuations, and operations in China, NUS remains significantly undervalued compared to competitors, presenting substantial upside potential. Read the full article on Seeking Alpha
Analysis Article • Dec 21

Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Analysis Article • Nov 12

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha • Nov 12

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Summary Nu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings disappointments, optimistic 2025-2026 EPS growth projections and multiple revenue catalysts suggest significant upside potential in the company's valuation. The company's global market expansion, cash acquisitions of LifeDNA and BeautyBio, and innovative product launches are key drivers for future net sales growth. NUS appears undervalued, trading below tangible book value per share, with conservative free cash flow forecasts indicating a fair price close to $15 per share. Read the full article on Seeking Alpha
Analysis Article • Oct 04

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

To the annoyance of some shareholders, Nu Skin Enterprises, Inc. ( NYSE:NUS ) shares are down a considerable 27% in the...
Analysis Article • Aug 31

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

What underlying fundamental trends can indicate that a company might be in decline? Businesses in decline often have...
Analysis Article • Aug 13

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

You may think that with a price-to-sales (or "P/S") ratio of 0.2x Nu Skin Enterprises, Inc. ( NYSE:NUS ) is a stock...
Analysis Article • May 30

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Key Insights Nu Skin Enterprises' Annual General Meeting to take place on 5th of June Total pay for CEO Ryan Napierski...
Analysis Article • May 13

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

NUSUS Personal ProductsUS Market
7D3.3%6.8%2.5%
1Y-22.2%-17.9%26.4%

Return vs Industry: NUS underperformed the US Personal Products industry which returned -15.2% over the past year.

Return vs Market: NUS underperformed the US Market which returned 28.7% over the past year.

Price Volatility

Is NUS's price volatile compared to industry and market?
NUS volatility
NUS Average Weekly Movement5.2%
Personal Products Industry Average Movement7.9%
Market Average Movement7.2%
10% most volatile stocks in US Market16.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: NUS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: NUS's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19842,800Ryan Napierskiwww.nuskin.com

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus.

Nu Skin Enterprises, Inc. Fundamentals Summary

How do Nu Skin Enterprises's earnings and revenue compare to its market cap?
NUS fundamental statistics
Market capUS$287.90m
Earnings (TTM)US$54.53m
Revenue (TTM)US$1.44b
5.2x
P/E Ratio
0.2x
P/S Ratio

Is NUS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NUS income statement (TTM)
RevenueUS$1.44b
Cost of RevenueUS$442.38m
Gross ProfitUS$998.90m
Other ExpensesUS$944.38m
EarningsUS$54.53m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)1.12
Gross Margin69.31%
Net Profit Margin3.78%
Debt/Equity Ratio28.2%

How did NUS perform over the long term?

See historical performance and comparison

Dividends

4.1%
Current Dividend Yield
22%
Payout Ratio

Does NUS pay a reliable dividends?

See NUS dividend history and benchmarks
When do you need to buy NUS by to receive an upcoming dividend?
Nu Skin Enterprises dividend dates
Ex Dividend DateMay 29 2026
Dividend Pay DateJun 10 2026
Days until Ex dividend1 day
Days until Dividend pay date13 days

Does NUS pay a reliable dividends?

See NUS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 15:50
End of Day Share Price 2026/05/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nu Skin Enterprises, Inc. is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olivia Tong CheangBofA Global Research
April SceeBTIG
Scott Van WinkleCanaccord Genuity